AbstractThe elucidation of the human and mouse genome sequence and developments in high-throughput genome analysis, and in computational tools, have made it possible to profile entire cancer genomes. In parallel with these advances mouse models of cancer have evolved into a powerful tool for cancer gene discovery. Here we discuss the approaches that may be used for cancer gene identification in both human and mouse and discuss how a cross-species ‘oncogenomics’ approach to cancer gene discovery represents a powerful strategy for finding genes that drive tumourigenesis
As many as 5 % of human cancers appear to be of hereditable etiology. Of the more than 50 characteri...
Advances in the field of molecular biology have resulted in a decent understanding of the causes for...
Highly rearranged and mutated cancer genomes present major challenges in the identification of patho...
With the proliferation of high-throughput technologies to profile the cancer genome, methods to dist...
The completion of the human genome project has enabled several new technologies for studying cancer ...
The complexity of genomic aberrations in most human tumors hampers delineation of the genes that dri...
Cancer is a complex disease in which cells progressively accumulate mutations disrupting their cellu...
Comparative genomic hybridization (CGH) can reveal important disease genes but the large regions ide...
Large-scale cancer genome projects will soon be able to sequence many cancer genomes to comprehensiv...
Human cancer cell lines and xenografts are valuable samples for whole- genome sequencing of human ca...
Transposon-mediated forward genetics screening in mice has emerged as a powerful tool for cancer gen...
AbstractCurrently, human cancer genomics is making great progress, and many mutations of new cancer ...
Phenotype-driven mutagenesis approaches in the mouse will deliver a vastly expanded mouse mutant res...
Although many genes that lead to different types of cancer when mutated have been identified, the ce...
Cancer and genomics. Identification of the genes that cause oncogenesis is a central aim of cancer r...
As many as 5 % of human cancers appear to be of hereditable etiology. Of the more than 50 characteri...
Advances in the field of molecular biology have resulted in a decent understanding of the causes for...
Highly rearranged and mutated cancer genomes present major challenges in the identification of patho...
With the proliferation of high-throughput technologies to profile the cancer genome, methods to dist...
The completion of the human genome project has enabled several new technologies for studying cancer ...
The complexity of genomic aberrations in most human tumors hampers delineation of the genes that dri...
Cancer is a complex disease in which cells progressively accumulate mutations disrupting their cellu...
Comparative genomic hybridization (CGH) can reveal important disease genes but the large regions ide...
Large-scale cancer genome projects will soon be able to sequence many cancer genomes to comprehensiv...
Human cancer cell lines and xenografts are valuable samples for whole- genome sequencing of human ca...
Transposon-mediated forward genetics screening in mice has emerged as a powerful tool for cancer gen...
AbstractCurrently, human cancer genomics is making great progress, and many mutations of new cancer ...
Phenotype-driven mutagenesis approaches in the mouse will deliver a vastly expanded mouse mutant res...
Although many genes that lead to different types of cancer when mutated have been identified, the ce...
Cancer and genomics. Identification of the genes that cause oncogenesis is a central aim of cancer r...
As many as 5 % of human cancers appear to be of hereditable etiology. Of the more than 50 characteri...
Advances in the field of molecular biology have resulted in a decent understanding of the causes for...
Highly rearranged and mutated cancer genomes present major challenges in the identification of patho...